Skip to main content
Premium Trial:

Request an Annual Quote

John Maraganore, Tod Woolf, Cy Stein, Mace Rothenberg, Ayad Al-Katib, David Olson, Craig Webb, John Schimenti, and Terry Magnuson

Alnylam Pharmaceuticals President and CEO John Maraganore has joined the board of immunotherapeutic developer MacroGenics.
"MacroGenics is a very promising immunotherapeutics company with a therapeutically and commercially attractive development pipeline," Maraganore said in a statement. "The company's innovative engineering platform offers a novel approach to enhancing monoclonal antibody therapeutics and has potential applicability in a wide range of diseases including cancer, autoimmune disorders, infectious disease, and allergy.”

ProNAi Therapeutics, which is developing DNA interference-based therapies, last week named its new scientific advisory board.
Joining the company’s SAB is Tod Woolf, founder and CEO of Ipifini. Woolf previously founded RNAi oligo shop Sequitur, which was acquired by Invitrogen in late 2003 (see RNAi News, 11/7/2003).
Also joining ProNAi’s SAB is Cy Stein, professor and head of genitourological cancer at Albert Einstein College of Medicine and long-time antisense and RNAi researcher.
Other members of ProNAi’s SAB are Mace Rothenberg, professor of medicine at Vanderbilt Medical School; Ayad Al-Katib, head of oncology at St. Johns Medical Center and professor of medicine at Wayne State University Medical School; David Olson, vice president of research at PanCell and co-founder of Gentera; Craig Webb, director of the multiple myeloma laboratory at the Van Andel Research Institute; John Schimenti, professor and director of vertebrate genomics at Cornell University; and Terry Magnuson, professor and chair of genetics at the University of North Carolina, Chapel Hill.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.